Brazil Approves Emergency Use of First Covid Vaccines

54-year-old Brazilian nurse Monica Calazans was the first person in Brazil to receive a dose of the Sinovac Covid-19 vaccine on Sunday. Brazil granted approval for the emergency use of AstraZeneca Plc and Sinovac Biotech Ltd vaccines against Covid-19, allowing the country to kick-start deploying shots as the virus roars back in Latin America’s largest economy. Health regulator Anvisa cleared the vaccines in a Sunday meeting, citing the recent significant increase in the number of Covid-19 cases in Brazil and the lack of alternatives for treatment of the disease. While government technicians said there’s still information needed on the shots, the benefits of vaccinations outweigh the risks, according to rapporteur Meiruze Freitas. “We must continue monitoring the vaccines to capture adverse effects that were perhaps not seen in trials,” she said. Minutes after Anvisa finished its meeting, Sao Paulo began vaccinations, making Monica Calazans, a 54-year-old Black nurse, the first Brazilian to get a shot against Covid-19. Governor Joao Doria stood by her side with a shirt that read, “Brazil’s vaccine.” The health ministry had said it would take between three to five days for the shots to arrive in all states, and vaccination would start simultaneously across the country. The elderly and health-care workers are first in line. Only Shot Although it’s one of the countries hit hardest by the pandemic, ranking third globally in cases and second only to the U.S. in number of deaths, Brazil been late in vaccinating its 212 million citizens. Much like in the first phase of the pandemic, national vaccination plans have been marred by contradicting measures and political infighting. Sinovac’s shot, bashed publicly by President Jair Bolsonaro “because of its origin” in China, has become the sole option available for the country to start immunizing its 212 million people. The only other vaccine the government has purchased, AstraZeneca’s, has yet to arrive in Brazil. Fiocruz, which will produce the shot locally, had forecast it would have doses ready just in February and a last minute push to get ready-made vaccines from India, announced by the health ministry last week, failed. A plane expected to fetch 2 million doses in Mumbai was diverted to deploy oxygen to the Northern city of Manaus instead, while the flight to India remains on hold. Talks with other pharmaceutical companies including Pfizer Inc have dragged. Earlier this month, Health Minister Eduardo Pazuello harshly dismissed criticism that Brazil was falling behind in the vaccination race, saying the government had secured 354 million doses. At the time, he also said there weren’t enough shots available on the open market -- conceding, in effect, that Brazil had failed to seek them early -- and so the country would have to make its own. Sao Paulo already has some 11 million doses of the Sinovac shot, dubbed CoronaVac, on the ground. The vaccine is being made in partnership with local research institute Butantan. AstraZeneca partnered with another local player, Fiocruz, to produce the shots in Brazil. On Saturday, Anvisa returned documents filed as part of an emergency use request for the Russian vaccine Sputnik V. Pharmaceutical company Uniao Quimica, which plans to produce the shot locally, did not comply with the minimum requirements for submission and analysis, the regulator said in a statement. “It is not enough to file a request for phase 3 clinical studies,” Anvisa said, adding the trials must be underway before seeking emergency authorization.Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world. To watch complete coverage on Bloomberg Quicktake 24/7, visit http://www.bloomberg.com/qt/live, or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app. Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake: https://cor.us/surveys/27AF30 Connect with us on… YouTube: https://www.youtube.com/user/Bloomberg Breaking News on YouTube: https://www.youtube.com/c/BloombergQuickTakeNews Twitter: https://twitter.com/quicktake Facebook: https://www.facebook.com/quicktake Instagram: https://www.instagram.com/quicktake